Skip to main content
. 2021 Feb 24;12:632937. doi: 10.3389/fimmu.2021.632937

Table 2.

Advantages and disadvantages of CAR-T Cells therapy in Multiple Myeloma.

Advantages Disadvantages
Novel therapy for refractory/relapsed patients Potentially can cause life-threatening complications
Recognize cells without HLA expression Relapses after treatment (antigen escape)
Eliminates only cells with targeted antigen Immunogenicity of CARs
One-time treatment with long therapy-free intervals providing patients with a high quality of life High costs of the therapy